Advanced Biomed Inc. Common Stock (ADVB) vs Aprea Therapeutics, Inc. (APRE)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and Aprea Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.34HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
APRE
Aprea Therapeutics, Inc.
$0.68HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADVB vs APRE
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)APRE -74.4% (-49.4%/yr)APRE compounded faster over this window
ADVB APRE
ADVB vs APRE: by the numbers
- •ADVB is the larger company ($9M vs $8M market cap).
Metrics side by side
Valuation
| Metric | ADVB | APRE |
|---|---|---|
| P/B ratio | 0.95 | 0.22 |
Profitability
| Metric | ADVB | APRE |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -7.36% | -31.99% |
| ROIC | -11.06% | -33.73% |
Growth (annualized)
| Metric | ADVB | APRE |
|---|---|---|
| Total return CAGR (5Y) | N/A | -63.30% |
Go deeper
Dig into the metrics
Advanced Biomed Inc. Common Stock ROEAprea Therapeutics ROEAdvanced Biomed Inc. Common Stock operating marginAprea Therapeutics operating marginAdvanced Biomed Inc. Common Stock revenue growthAprea Therapeutics revenue growthAdvanced Biomed Inc. Common Stock free cash flowAprea Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.